17448V-INTERVENTIONOpenEvaluation of inclisiran versus placebo for the prevention of major adverse cardiovascular and limb events in patients undergoing percutaneous coronary intervention or peripheral endovascular intervention NCT06909565IndustrialAdultTreatmentIVNationalOtherCase, BrianMedstar Southern Maryland Hospital CenterMCRN - Southern Maryland2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>